Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Risk of Recurrence of Adverse Events Following Immunization: A Systematic Review.

Zafack JG, De Serres G, Kiely M, Gariépy MC, Rouleau I, Top KA; Canadian Immunization Research Network .

Pediatrics. 2017 Sep;140(3). pii: e20163707. doi: 10.1542/peds.2016-3707. Review.

2.

Rate of Recurrence of Adverse Events Following Immunization: Results of 19 Years of Surveillance Ii Quebec, Canada.

Zafack JG, Toth E, Landry M, Drolet JP, Top KA, De Serres G.

Pediatr Infect Dis J. 2018 Sep 10. doi: 10.1097/INF.0000000000002162. [Epub ahead of print]

PMID:
30204662
3.

A systematic review of adverse events following immunization during pregnancy and the newborn period.

Fulton TR, Narayanan D, Bonhoeffer J, Ortiz JR, Lambach P, Omer SB.

Vaccine. 2015 Nov 25;33(47):6453-65. doi: 10.1016/j.vaccine.2015.08.043. Epub 2015 Sep 26. Review.

4.

Systematic review of reporting rates of adverse events following immunization: an international comparison of post-marketing surveillance programs with reference to China.

Guo B, Page A, Wang H, Taylor R, McIntyre P.

Vaccine. 2013 Jan 11;31(4):603-17. doi: 10.1016/j.vaccine.2012.11.051. Epub 2012 Nov 29. Review.

PMID:
23200940
5.

Pediatric anaphylactic adverse events following immunization in Victoria, Australia from 2007 to 2013.

Cheng DR, Perrett KP, Choo S, Danchin M, Buttery JP, Crawford NW.

Vaccine. 2015 Mar 24;33(13):1602-7. doi: 10.1016/j.vaccine.2015.02.008. Epub 2015 Feb 16.

PMID:
25698493
6.

Surveillance of adverse events following immunisation: Australia, 2000-2002.

Lawrence G, Menzies R, Burgess M, McIntyre P, Wood N, Boyd I, Purcell P, Isaacs D.

Commun Dis Intell Q Rep. 2003;27(3):307-23.

7.

Adverse events following immunization in patients with primary immunodeficiencies.

Sarmiento JD, Villada F, Orrego JC, Franco JL, Trujillo-Vargas CM.

Vaccine. 2016 Mar 18;34(13):1611-1616. doi: 10.1016/j.vaccine.2016.01.047. Epub 2016 Feb 2.

PMID:
26850760
8.

Vaccine Safety and Surveillance for Adverse Events Following Immunization (AEFI) in India.

Joshi J, Das MK, Polpakara D, Aneja S, Agarwal M, Arora NK.

Indian J Pediatr. 2018 Feb;85(2):139-148. doi: 10.1007/s12098-017-2532-9. Epub 2017 Nov 23. Review.

PMID:
29170922
9.

Adverse Events Following Immunization in Brazil: Age of Child and Vaccine-Associated Risk Analysis Using Logistic Regression.

Lopes SRC, Perin JLR, Prass TS, Carvalho SMD, Lessa SC, Dórea JG.

Int J Environ Res Public Health. 2018 Jun 1;15(6). pii: E1149. doi: 10.3390/ijerph15061149.

10.

[Surveillance of adverse events following immunization in Minhang district of Shanghai from 2007 to 2010].

Zhang LP, Yu F, Jin BF, Wang Y, Xu HL, DU Y.

Zhonghua Er Ke Za Zhi. 2012 Nov;50(11):859-64. Chinese.

PMID:
23302620
11.

A global survey of adverse event following immunization surveillance systems for pregnant women and their infants.

Cassidy C, MacDonald NE, Steenbeek A, Ortiz JR, Zuber PL, Top KA.

Hum Vaccin Immunother. 2016 Aug 2;12(8):2010-2016. Epub 2016 May 9.

12.

Immunizing Patients With Adverse Events After Immunization and Potential Contraindications to Immunization: A Report From the Special Immunization Clinics Network.

Top KA, Billard MN, Gariepy MC, Rouleau I, Pernica JM, Pham-Huy A, Quach C, Tran D, Vaudry W, Dobson S, Boucher FD, Carignan A, Jadavji T, McConnell A, McNeil SA, Halperin SA, De Serres G; Canadian Immunization Research Network’s (CIRN) Special Immunization Clinics Network investigators.

Pediatr Infect Dis J. 2016 Dec;35(12):e384-e391.

PMID:
27626920
13.

[Surveillance of adverse events following immunization in Henan Province, China between 2010-2011].

Ye Y, Wang CS, Ma YT, Lu MX, Zhang XX, Zhang YY, Guo WS.

Zhongguo Dang Dai Er Ke Za Zhi. 2013 Jun;15(6):466-71. Chinese.

14.

A cohort event monitoring to determine the adverse events following administration of mouse brain derived, inactivated Japanese Encephalitis vaccine in an endemic district in Sri Lanka.

De Alwis KN, Abeysinghe MR, Wickramesinghe AR, Wijesinghe PR.

Vaccine. 2014 Feb 12;32(8):924-30. doi: 10.1016/j.vaccine.2013.12.047. Epub 2014 Jan 7.

PMID:
24406391
15.

Application of the revised WHO causality assessment protocol for adverse events following immunization in India.

Singh AK, Wagner AL, Joshi J, Carlson BF, Aneja S, Boulton ML.

Vaccine. 2017 Jul 24;35(33):4197-4202. doi: 10.1016/j.vaccine.2017.06.027. Epub 2017 Jun 22.

PMID:
28648545
16.

Surveillance for adverse events following immunization (AEFI) in Switzerland--1991-2001.

Schumacher Z, Bourquin C, Heininger U.

Vaccine. 2010 May 28;28(24):4059-64. doi: 10.1016/j.vaccine.2010.04.002. Epub 2010 Apr 18.

PMID:
20406662
17.
18.

Anxiety-related adverse events following immunization (AEFI): A systematic review of published clusters of illness.

Loharikar A, Suragh TA, MacDonald NE, Balakrishnan MR, Benes O, Lamprianou S, Hyde TB, McNeil MM.

Vaccine. 2018 Jan 4;36(2):299-305. doi: 10.1016/j.vaccine.2017.11.017. Epub 2017 Nov 29. Review.

PMID:
29198916
19.

Vaccine safety implications of Ontario, Canada's switch from DTaP-IPV to Tdap-IPV for the pre-school booster.

Klar S, Harris T, Wong K, Fediurek J, Deeks SL.

Vaccine. 2014 Nov 12;32(48):6360-3. doi: 10.1016/j.vaccine.2014.09.017. Epub 2014 Sep 22.

PMID:
25252195
20.

Surveillance of adverse events following immunisation: Australia 2002 to 2003.

Lawrence G, Boyd I, McIntyre P, Isaacs D.

Commun Dis Intell Q Rep. 2004;28(3):324-38.

Supplemental Content

Support Center